Bone Medical completes merger with Revenir

By Melissa Trudinger
Monday, 23 August, 2004

UK biotech company Bone Limited has completed its merger with Perth-based listed property management company Revenir (ASX: REV) after a successful capital raising of $2.5 million closed oversubscribed earlier in the month.

The company, which will be known as Bone Medical, is expected to start trading on August 31, 2004 under the stock symbol BNE.

Cancer drug enters clinical trials based on a false mechanism

A cancer drug currently being tested in patients appears to have entered clinical trials based on...

Russia insists there is "no plague case" following lab worker death

Russian health authorities say there is no evidence that pneumonic plague played a part in the...

Scientists 'reprogram' tumour-supporting immune cells

The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...

Content from other channels on our network

Conviction and $20K fine follows "serious and prolonged" offending by former podiatrist

Supagas acquires Heeson Medical

Why digital resilience is becoming critical in aged care

Rapid-response discharge model targets bed block

A Good Cleaning Schedule: Best Practices for Healthcare Facilities

Study assesses recycled content use in home builds

Smart bin receives 2026 Australian Good Design Award

Industrial electricity costs could halve by sharing infrastructure

Epson MD serves meals for CEO CookOff

AI solar smart bins to end Vic fixed-route rubbish runs

Beverage facility built to keep the good times rolling

Six on the shelf: from frozen treats to smoothies & meal kits

58% of food manufacturers report less productivity, research finds

Leadership change at CCEP Australia next year

CCEP's $39.7m can line upgrade in Perth increases capacity 40%